Zonenshayn M, Rezai A R, Mogilner A Y, Beric A, Sterio D, Kelly P J
New York University Center for Functional and Restorative Neurosurgery, New York University School of Medicine, New York, USA.
Neurosurgery. 2000 Aug;47(2):282-92; discussion 292-4. doi: 10.1097/00006123-200008000-00005.
The subthalamic nucleus (STN) has recently become the surgical target of choice for the treatment of medically refractory idiopathic Parkinson's disease. A number of anatomic and physiological targeting methods have been used to localize the STN. We retrospectively reviewed the various anatomic targeting methods and compared them with the final physiological target in 15 patients who underwent simultaneous bilateral STN implantation of deep brain stimulators.
The x, y, and z coordinates of our localizing techniques were analyzed for 30 STN targets. Our final targets, as determined by single-cell microelectrode recording, were compared with the following: 1) targets selected on coronal magnetic resonance inversion recovery and T2-weighted imaging sequences, 2) the center of the STN on a digitized scaled Schaltenbrand-Wahren stereotactic atlas, 3) targeting based on a point 13 mm lateral, 4 mm posterior, and 5 mm inferior to the midcommissural point, and 4) a composite target based on the above methods.
All anatomic methods yielded targets that were statistically significantly different (P < 0.001) from the final physiological targets. The average distance error between the final physiological targets and the magnetic resonance imaging-derived targets was 2.6 +/- 1.3 mm (mean +/- standard deviation), 1.7 +/- 1.1 mm for the atlas-based method, 1.5 +/- 0.8 mm for the indirect midcommissural method, and 1.3 +/- 1.1 mm for the composite method. Once the final microelectrode-refined target was determined on the first side, the final target for the contralateral side was 1.3 +/- 1.2 mm away from its mirror image.
Although all anatomic targeting methods provide accurate STN localization, a combination of the three methods offers the best correlation with the final physiological target. In our experience, direct magnetic resonance targeting was the least accurate method.
丘脑底核(STN)最近已成为治疗药物难治性特发性帕金森病的首选手术靶点。已采用多种解剖学和生理学靶向方法来定位STN。我们回顾性分析了15例接受双侧STN深部脑刺激器同时植入患者的各种解剖学靶向方法,并将其与最终的生理学靶点进行比较。
对30个STN靶点的定位技术的x、y和z坐标进行分析。将通过单细胞微电极记录确定的最终靶点与以下靶点进行比较:1)在冠状面磁共振反转恢复和T2加权成像序列上选择的靶点;2)数字化缩放的Schaltenbrand-Wahren立体定向图谱上STN的中心;3)基于在连合中点外侧13 mm、后方4 mm和下方5 mm处的点进行的靶向;4)基于上述方法的复合靶点。
所有解剖学方法得出的靶点与最终生理学靶点在统计学上均有显著差异(P < 0.001)。最终生理学靶点与磁共振成像得出的靶点之间的平均距离误差为2.6±1.3 mm(均值±标准差),基于图谱的方法为1.7±1.1 mm,间接连合中点法为1.5±0.8 mm,复合方法为1.3±1.1 mm。一旦在一侧确定了最终经微电极优化的靶点,对侧的最终靶点与其镜像靶点相距1.3±mm。
尽管所有解剖学靶向方法都能提供准确的STN定位,但三种方法结合使用与最终生理学靶点的相关性最佳。根据我们的经验,直接磁共振靶向是最不准确的方法。